Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.; Correction
---
identifier: "/us/fr/2013-31362"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2013-31362"
section_name: "Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.; Correction"
positive_law: false
currency: "2014-01-02"
last_updated: "2014-01-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2013-31362"
document_type: "notice"
publication_date: "2014-01-02"
agencies:
- "Justice Department"
- "Drug Enforcement Administration"
fr_citation: "79 FR 151"
fr_volume: 79
---
# Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc.; Correction
In *Federal Register* (FR DOC) 2013-25096 on page 64019, in the issue of Friday, October 25, 2013, make the following corrections:
On page 64019, in the first column, in the table, the first cell inadvertently omitted basic class of controlled substance Amphetamine (1100), and the second column, in the table, the last cells should read “II”.
Dated: December 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.